Investor profile
Jeffrey Aronin
Angel, Operator angel & Board of Directors at The Aspen Institute, Chairman and CEO at Paragon Biosciences
An angel investor and operator angel based in United States, Jeffrey Aronin has one known investment, eMed.
Is Jeffrey Aronin a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Series A
- Sector
- Healthcare
- Focus
- BiotechClinical TrialsDrug DevelopmentLife ScienceMedTechNeuropsychiatric DisordersPharmaceuticalsRegenerative Medicine
Contacts
Jeffrey Aronin portfolio company (1)
- eMed
Affiliated funds' portfolios
Board of Directors at The Aspen Institute, whose known portfolio counts 10 companies
- E Cubed
- Digify Africa
- Dignity For Children Foundation
- IIDEAC
- Lacana
- National Cancer Society of Malaysia
- SOLS 24/7
- Siyafunda CTC
- Startup Lab MX
- UNETE
Chairman and CEO at Paragon Biosciences, whose known portfolio counts 3 companies
- Castle Creek Biosciences
- Emalex Biosciences
- Evozyne
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Development and Life Science. Startups operating in these areas may find Jeffrey Aronin relevant.
The stage tag on this profile is Series A.
The portfolio and focus above give founders context on whether Jeffrey Aronin matches their raise.
Colleagues
Showing 20 of 39
Dylan Taylor
Henry Crown Fellow
Denver, United States
Amit Anand
Aspen Finance Leaders Fellow
Singapore
Gary Lauder
Henry Crown Fellow
San Francisco, United States
Kunal Bajaj
Fellow
Mumbai, India
Ryan Nece
Henry Crown Fellow
San Francisco, United States
Julia Hartz
Henry Crown Fellow
San Francisco, United States
Brett A. Hurt
Henry Crown Fellow
Austin, United States
Daniel Laury
Visiting Fellow
San Francisco, United States
Joshua Baer
Henry Crown Fellow
Austin, United States
Heidi Zak
Henry Crown Fellow
San Francisco, United States
Abhishek Shah
Fellow
Dubai, United Arab Emirates
Rodrigo Garcia
Fellow, Global Finance Leaders
San Diego, United States
Mohit Sadaani
Fellow
Gurgaon, India
Kabir Barday
Henry Crown Fellow (Class of 2023)
Atlanta, United States
Jason Mayden
Henry Crown Fellow
Los Angeles, United States
William Canestaro
Better Arguments Ambassador
Seattle, United States
Yinglan Tan
Fellow
Singapore
Spiro Katerinis
Investor
Niles, United States
Sietse Jonkman
VP, Portfolio Management
Chicago, United States
Ami Dror
Henry Crown Fellow
Tel Aviv-Yafo, Israel
Similar investors
Showing 20 of 98
Yury Kukushkin
angel investor
Boston, United States
Ted Love
operator angel
Barbara Lubash
angel investor
Orange County, United States
David Wiersma
angel investor
Tucson, United States
Michael Chambers
angel investor and operator angel
Fargo, United States
Daniel Bradbury
angel investor and operator angel
San Diego, United States
Margo Georgiadis
Managing Partner
San Francisco, United States
Robin Stracey
angel investor and operator angel
Reno, United States
Ken Haas
angel investor
San Francisco, United States
Alan Parnham
angel investor and operator angel
Southport, Australia
Shaunak Parikh
angel investor
New York, United States
Paul Grint
angel investor
San Diego, United States
Roger Jeffs
angel investor and operator angel
Raleigh, United States
Anurag Agarwal
angel investor and operator angel
Philadelphia, United States
Carol Gallagher
angel investor and operator angel
Del Mar, United States
Chris Jackson
angel investor and operator angel
New York, United States
David Steinberg
angel investor and operator angel
Milton, United States
Peter Hecht
angel investor and operator angel
Cambridge, United States
Andrew Sandford
angel investor
Boston, United States
Dennis Purcell
Founder and Senior Advisor
New York, United States
Frequently asked questions
Who is Jeffrey Aronin?
Jeffrey Aronin is an angel investor and operator angel based in United States with one known investment on file, eMed. The sections above list the sectors, stages and firms attached to that record.
What does Jeffrey Aronin invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Development and Life Science. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Jeffrey Aronin invest at?
The database lists Jeffrey Aronin for Series A rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Jeffrey Aronin listed at?
Jeffrey Aronin is listed as Board of Directors at The Aspen Institute. 39 other people in the database share a firm with Jeffrey Aronin.
How do I contact Jeffrey Aronin?
A LinkedIn page is on file for Jeffrey Aronin. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal